• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

image

PLAY BUTTON

image

PLAY BUTTON

image

Progress

1/72

Click to flip

72 Cards in this Set

  • Front
  • Back
Anemias due to increased destruction of red cells
Hemolytic anemias
is associated with a release of hemoglobin and lactic acid dehydrogenase (LDH).
Hemolysis
Hemolysis may be either?
Intravascular or Extravascular
RBCs lyse in the circulation releasing hemoglobin into the plasma.

Causes include mechanical trauma, complement fixation, and other toxic damage to the RBC.

The fragmented RBCs are called schistocytes.
Intravascular hemolysis
RBCs are phagocytized by macrophages in the spleen and liver.

Causes include RBC membrane abnormalities such as bound immunoglobulin, or physical abnormalities restricting RBC deformability that prevent egress from the spleen.

This is characterized by spherocytes.
Extravascular hemolysis
If onset of hemolysis is abrupt:
What are the signs/symptoms?
Tachycardia and dyspnea
The anemia is severe
Patients with underlying cardiovascular disease and severe uncompensated hemolysis
May present with:
Angina
Heart failure symptoms

Hemosiderosis, leg ulcers, folate deficiency, and gallstones can also occur.
What are five main causes of hemolytic anemia?
Hereditary spherocytosis
G6PD deficiency
Sickle cell anemia
Acquired Hemolytic Anemias
Immune Mediated Hemolysis
is an autosomal dominant disease of variable severity

CHARACTERISTICS:
Defective or absent spectrin molecule
Leads to loss of RBC membrane, leading to spherocytosis
Decreased deformability of cell
Increased osmotic fragility
Extravascular hemolysis in spleen
Hereditary spherocytosis
Diagnosed during childhood
Anemia -may or may not be present (BM may compensate)
Severe Anemia:
Folate Deficiency
BM impaired by infection (Parvovirus B19)

Chronic hemolysis causes:
jaundice
Gallstones = cholecystitis
Examination = icterus and a palpable spleen
Signs and symptoms of hereditary spherocytosis
What are the laboratory findings with hereditary spherocytosis?
Hematocrit may be normal
Reticulocytosis is always present
The peripheral blood smear (PBS) *spherocytes *small cells that have lost their central pallor
microcytosis
increased MCHC
May be an increase in indirect (unconjugated ) bilirubin
The Coombs test is negative
How do you TX hereditary spherocytosis?
Treatment with uninterrupted supplementation with folic acid, 1 mg/d.
The treatment of choice is splenectomy (will eliminate the site of hemolysis).

In very mild cases discovered late in adult life, splenectomy may not be necessary.
is the most common disease-producing enzymopathy in humans

Inherited as an X-linked disorder

Affects 400 million people worldwide

The disease is highly polymorphic, with more than 300 reported variants. It confers protection against malaria, which probably accounts for its high gene frequency.
(G6PD) deficiency
is a housekeeping enzyme critical in the redox metabolism of all aerobic cells.
Glucose 6-phosphate dehydrogenase (G6PD)
G6PD regenerates?
NADPH (nicotinamide adenine dinucleotide phosphate), allowing regeneration of GSH (glutathione) defends the red cells against oxidative stress
leads to hemolysis during oxidative stress.

Causative agents:
Infection
Medications
Fava beans

Oxidative stress leads to Heinz body formation and extravascular hemolysis
Lack of G6PD
The spleen pinches off the Heinz body and the overlying membrane, leaving a “bite cell” or “blister cell”
(G6PD) deficiency
This is associated with an abrupt fall in the hemoglobin concentration of 3 to 4 g/dL, and the peripheral blood smear reveals cell fragments, microspherocytes, and eccentrocytes or "bite" cells .
Heinz Bodies (G6PD) deficiency
The laboratory workup for (G6PD) deficiency includes the following:
Determine the level of anemia
Check bone marrow function by obtaining a CBC count with the reticulocyte count
Measure the actual enzyme activity of G6PD rather than the amount of (G6PD) protein.
Check the Indirect(unconjugated) Bilirubin

Check the serum Haptoglobin levels – These serve as an index of hemolysis and will be decreased.
a plasma protein whose only known function is to bind free hemoglobin.

The quantity of this is increased in certain chronic diseases and inflammatory disorders and is decreased or absent in hemolytic anemia.

Normal adult findings range from 100 to 150 mg/dL
Haptoglobin
What imaging studies may be useful in diagnosing G6PD deficiency?
Abdominal ultrasound may be useful in assessing for splenomegaly and gallstones in cases of (G6PD) deficiency.
How do you treat G6PD deficiency?
Identification and discontinuation of the precipitating agent is critical. Treat with oxygen and bed rest. Consultations: Consultations with the following specialists should be sought after - Hematologists, Geneticists.
Patients with (G6PD) deficiency should heed the following precautions:

Avoid:
Broad beans: i.e., fava beans

Infections : viral hepatitis, pneumonia
and typhoid fever.

Avoid oxidant drugs such as the antimalarial drugs
Avoid nitrofurantoin
Avoid nalidixic acid, ciprofloxacin, niridazole, norfloxacin, methylene blue, chloramphenicol, phenazopyridine, and vitamin K analogues
Avoid sulfonamides
Avoid exposure to certain chemicals such as those in mothballs
Infants with prolonged neonatal jaundice as a result of (G6PD) deficiency are?
placed under special lights (ie, bili lights) that alleviate jaundice.
Exchange transfusion may be necessary in cases of ?
severe neonatal jaundice or hemolytic anemia caused by favism.
One of the most common of the hemoglobinopathies is Hgb S. It is a qualitative hemoglobin disorder.


In this there is a point mutation in the ß-chain resulting in encoding of a valine instead of the normal glutamine.

This results in abnormal ßs chains combining with normal a-chains to form the abnormal hemoglobin 'S'

RBC’s take on sickled-shape when in presence of decreased O² tension
Sickle Cell Anemia
Under low oxygen, Hgb becomes insoluble forming long polymers

This leads to membrane changes (“sickling”) and vasoocclusion

Hemolytic anemia, not iron deficient
RBC distortion, 10-20 day lifespan (significantly shortened)
Sickle Cell Anemia
Deoxygenation of SS erythrocytes leads to intracellular hemoglobin polymerization, loss of deformability and changes in cell morphology.
Affects on red blood cells due to sickle cell anemia
What can be seen in the clinical presentation of sickle cell anemia?
Variable degrees of hemolysis

Intermittent episodes of vaso - occlusion

Tissue ischemia

Acute and chronic organ dysfunction
VOC - is caused by abnormally shaped red blood cells resulting in acute and chronic organ dysfunction
VOC- sickled cells occlude capillaries and small blood vessels
VOC - Obstructs blood flow causing tissue ischemia
VOC - Reduces blood flow causing further tissue hypoxia
VOC - Increased tissue hypoxia increases “sickling”
Vaso Occlusion
can occur in any tissue, most commonly affect extremities, lower back and abdomen

Can occur in any tissue or organ
Factors contributing to this include fever, hypoxia, dehydration, hypothermia, emotional stress or nothing
Vaso Occlusion
Vaso-occlusive crisis lasting longer than 7days search for other causes of bone pain:
Osteomyelitis
Avascular necrosis
Compression deformities

When a recurrent bone crisis lasts for weeks, an exchange transfusion may be required to abort the cycle.
What are three complications associated with sickle cell anemia?
Pain - difficult to manage with frequent recurrences

Increased risk of infection

Acute Chest Syndrome
How do you manage a sickle cell crisis?
Vasoocclusive crisis is treated with vigorous hydration and analgesics.

Intravenous fluids :to correct dehydration and to replace continuing loss. Normal saline and 5% dextrose in saline may be used.

These fluids should be given intravenously, and treatment must be in an inpatient setting.
What is the drug of choice for controlling pain in a sickle cell crisis?
Morphine
Chronic pain associated with sickle cell anemia is controlled how?
Chronic pain is managed with long-acting oral morphine preparations and acetaminophen and NSAIDs.

NSAIDs are effective in reducing deep bone pain. Patients may require breakthrough oral opiates also codeine and hydrocodone, are used first.
Sudden trapping of blood within the spleen. Usually occurs in infants under 2 years of age.
May be associated with fever, pain, and respiratory symptoms. Circulatory collapse and death can
occur in less than thirty minutes.
Splenic Sequestion
This is one of the first complications in sickle cell syndromes with the highest incidence between
ages six months and two years. The sickle red cells cause painful swelling of the hands and feet.
This is treated with fulids and pain medication. It usually will go away in a few days without any
problems.
Hand Foot Syndrome - Dactylitis
What are two other problems, apart from splenic sequestion and dactylitis, that are associated
with sickle cell anemia
Leg ulcers and eye problems (vascular damage to the eye)
The risk of this is 400 x greater in SCD than in the general population
#1 cause of death infants and young children

Functional asplenia by age 12 months

Predisposition to infection due to functional Asplenia

Prophylactic penicillin significantly reduces death from overwhelming infections
pneumoccocal sepsis/meningitis
leading cause of death in children & adults over age 5
Clinical presentation of pneumonia and pulmonary infarct may be indistinguishable
Causes: pulmonary infection S.aureus,
S.pneumoniae, chlamydia, mycoplasma, VOC of pulmonary vessels, fat embolism secondary to marrow infarction, RSV
Acute Chest Syndrome - Is a potentially fatal complication of SCD

Pathophysiology:
Acute chest syndrome is thought to be in situ sickling within the lung producing pain and temporary pulmonary dysfunction
Characterized by:
Chest pain, fever, pulmonary infiltrates & respiratory distress
Can be rapidly progressing
Antibiotics and oxygen are essentials of therapy
Transfusions beneficial in hypoxemic patients
Acute Chest Syndrome
How do you treat sickle cell disease?
Transfusion in Sickle Cell Disease

Used to increase the oxygen carrying
capacity of blood & decrease the proportion
of sickled red cells which will improve the
microvasculature perfusion of tissues

Each 3 cc/kg of PRBC will raise the Hb by
1 gm and decrease the Hgb S by 10%

Goal is to stop sickling by raising Hb and
decreasing amount of Hgb S
Indications for transfusion in SCD

EPISODIC/ACUTE
Management of Severe Anemia/Sudden Acute Illness:
Acute splenic sequestration
Aplastic crisis
Stroke

Hyperhemolysis associated with infection and acute chest syndrome
Indications for transfusion in SCD

CHRONIC/PROPHYLACTIC
Primary Prevention of Stroke
Prevention Of Stroke Recurrence
Treatment of Chronic Debilitating Pain
Pulmonary Hypertension
Chronic Renal Failure
Chronic Heart Failure
Leg ulcers
Priapism
Only known cure for SCD
STEM CELL TRANSPLANT
Drug therapies that change the structure of the red blood cell
Reduce sickling
Increase hemoglobin
RED BLOOD CELL MODIFIERS

Hydroxyurea, Decitabine,
ICA-17043, Butyrate
The only drug currently approved by the FDA for the treatment of SCD is ?
Hydroxyurea
increases the production of Hb F, which retards gelation and sickling.
Hydroxyurea
is a group of disorders characterized by a malfunction of the immune system that produces autoantibodies, which attack red blood cells as if they were substances foreign to the body.
Autoimmune hemolytic anemia
Autoimmune hemolytic anemia may be seen in association with?
systemic lupus erythematosus (SLE)
chronic lymphocytic leukemia (CLL)
lymphomas
The hallmark of this disease is a positive Coomb’s test
Auto-Immune Hemolytic Anemias
Warm and Cold
react with RBCs best at 37° and typically do not agglutinate red cells
warm antibodies
typically react best at <32° and do cause RBC agglutination
cold antibodies
Usually IgG antibodies
Fix complement only to level of C3, if at all
Immunoglobulin binding occurs at all temps
Fc receptors/C3b recognized by macrophages
Hemolysis primarily extravascular
70% associated with other illnesses
Responsive to steroids/splenectomy
Warm type autoimmune hemolysis
What are the laboratory features of warm type autoimmune hemolysis?
Splenomegaly, jaundice usually present.
• Depending on degree of anemia and rate of fall in hemoglobin, patients can have VERY symptomatic anemia
What are the laboratory results for warm type autoimmune hemolysis?
– ↑reticulocytes, ↑ bili, ↑ LDH,
– positive Coomb’s test - both direct and indirect.
– SPHEROCYTES are seen on the peripheral smear.
Looks for immunoglobulin &/or complement on surface of red blood cell (normally neither found on RBC surface)

Coombs reagent - combination of anti-human immunoglobulin & anti-human complement

Mixed with patient’s red cells; if immunoglobulin or complement are on surface, Coombs reagent will link cells together and cause agglutination of RBCs
Coomb's Test
How do you treat warm type autoimmune hemolysis?
Patients may require red cell transfusions, if they are symptomatic with their anemia

Immunosuppression is the mainstay of therapy
• First line is corticosteroids

• If steroids fail to work, or if patient relapses after steroid taper, splenectomy may be necessary

IVIg (intravenous IgG) can be used as adjunctive therapy

• Immunosuppressives such as cyclophosphamide or azathioprine may be required as third third-line therapy

Rituximab (anti-CD20 monoclonal antibody) has been used successfully
Warm-Antibody Hemolytic Anemias
Immunosuppressive Treatment
Most commonly IgM mediated
Antibodies bind best at 30º or lower
Fix entire complement cascade
Leads to formation of membrane attack complex, which leads to RBC lysis in vasculature
90% associated with other illnesses
Poorly responsive to steroids, splenectomy; responsive to plasmapheresis
AUTOIMMUNE HEMOLYSIS Cold Type
Cold agglutinin disease is associated with?
Lymphoma
Mycoplasma pneumonia
Infectious mononucleosis
Laboratory findings in cold agglutinin?
RBC polychromasia
Increased unconjugated bilirubin
Decreased haptoglobin
Hemoglobinuria
Less spherocytosis

In many cases agglutination of RBCs is seen on peripheral blood smears (room temperature).

C3 is found only on the RBC surface by the DAT.
Occurs when certain drugs interact with the red blood cell membrane, causing the cell to become antigenic.
Alpha-Methyl dopa type: levodopa, methyldopa.
Hapten type: Penicillins, cephalosporins.
Quinidine type: quinidine.
Others: mefenamic acid, salicylic acid, sulfonamides, Thiazide diuretics, antazoline, chlorpromazine, isoniazid, streptomycin, ibuprofen
Drug induced hemolytic anemia
Drug-induced hemolytic anemia is most often associated with
G6PD deficiency
Drug binds to & reacts with red cell surface proteins
Antibodies recognize altered protein, ± drug, as foreign
Antibodies bind to altered protein & initiate process leading to hemolysis
Drug induced hemolytic anemia
• Arsenic - especially arsine gas
• Lead - produces some shortening of RBC lifespan, but anemia mainly due to defect in heme synthesis.
• Copper - deliberate ingestion, accumulation of toxic amounts from dialysis fluid exposed to copper pipes, and Wilson’s disease.
• Insect, spider (esp brown recluse), snake venoms
• Heat/burns
Hemolysis Associated with
Chemical and Physical Agents
“The great impersonator”
because of the variety of symptoms observed during the initial manifestation and course
paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

3 types of symptoms including:
(1) an acquired intracorpuscular hemolytic anemia due to the abnormal susceptibility of the RBC membrane to the hemolytic activity of complement

(2) thromboses in large vessels, such as hepatic, abdominal, cerebral, and subdermal veins

(3) a deficiency in hematopoiesis that may be mild or severe
such as pancytopenia in an aplastic anemia state
Acquired Clonal cell disorder ( remember Aplastic Anemia?)
Ongoing Intra- & Extravascular hemolysis; classically at night (can occur throughout the day)
Testing
Elevated LDH,
The white blood cell count and platelet count may be decreased.
A decreased leukocyte alkaline phosphatase
Flow cytometric assays may confirm the diagnosis by demonstrating the absence of CD59
(a complement-regulating protein)
paroxysmal nocturnal hemoglobinuria (PNH)
PNH may have three components, they are?
intravascular hemolysis

inadequate erythropoiesis

superimposed iron deficiency (massive iron loss through hemoglobinuria)
How do you treat PNH?
Iron replacement is indicated for treatment of iron deficiency

Increased rate of erythropoiesis = give 5 mg/d of folic acid orally

Prednisone is effective in decreasing hemolysis (some patients can be managed effectively with alternate-day steroids)

In severe cases allogeneic bone marrow transplantation has been used to treat the disorder.